Stevanato Group (NYSE:STVN) Director Elisabetta Magistretti Sells 2,045 Shares

Stevanato Group S.p.A. (NYSE:STVN) Director Elisabetta Magistretti sold 2,045 shares of the firm’s stock in a transaction on Friday, August 7th. The shares were sold at an average price of €20.09, for a total value of €41,084.05. Following the transaction, the director owned 2,930 shares of the company’s stock, valued at €58,863.70. The trade was a 41.11% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Stevanato Group Stock Performance

Shares of Stevanato Group stock opened at €20.65 on Tuesday. The stock has a market cap of $6.25 billion, a price-to-earnings ratio of 36.87, a PEG ratio of 1.70 and a beta of 0.77. The firm’s 50-day moving average is €18.84 and its 200 day moving average is €16.98. Stevanato Group S.p.A. has a 1 year low of €12.89 and a 1 year high of €28.00. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.61 and a quick ratio of 1.08.

Analyst Ratings Changes

STVN has been the topic of a number of recent analyst reports. TD Cowen upgraded shares of Stevanato Group to a “strong-buy” rating in a report on Wednesday, June 17th. Wolfe Research began coverage on shares of Stevanato Group in a report on Tuesday, June 2nd. They issued an “outperform” rating and a $21.00 price objective for the company. Finally, Weiss Ratings raised Stevanato Group from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday, July 16th. Two investment analysts have rated the stock with a Strong Buy rating, two have given a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Buy”.

Institutional Investors Weigh In On Stevanato Group

A number of hedge funds have recently added to or reduced their stakes in STVN. Conestoga Capital Advisors LLC boosted its stake in shares of Stevanato Group by 7.6% in the 1st quarter. Conestoga Capital Advisors LLC now owns 8,491,751 shares of the company’s stock worth $116,762,000 after buying an additional 602,050 shares during the last quarter. Fideuram Intesa Sanpaolo Private Banking S.P.A. bought a new stake in shares of Stevanato Group during the 4th quarter valued at about $9,269,000. Norges Bank purchased a new stake in shares of Stevanato Group during the 4th quarter valued at about $8,185,000. Credit Agricole S A bought a new position in shares of Stevanato Group in the 3rd quarter worth approximately $9,785,000. Finally, T. Rowe Price Investment Management Inc. boosted its holdings in shares of Stevanato Group by 10.4% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 3,923,632 shares of the company’s stock worth $78,944,000 after buying an additional 368,792 shares during the last quarter.

Stevanato Group Company Profile

Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.

In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.